Global Commercial Property Management Software Market Report 2020-2025 by Technology, Trends,Top Key Players and more…

A new market study, titled “Global Commercial Property Management Software Market Size, Status and Forecast 2020-2026”, has been featured on WiseGuyReports.

PUNE, MAHARASTRA, INDIA, April 1, 2020 /EINPresswire.com/ — Commercial Property Management Software Market

This report focuses on the global Commercial Property Management Software status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Commercial Property Management Software development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
AppFolio
Yardi Breeze
RealPage
SKYLINE
MRI Commercial Management
Property Boulevard
Axxerion
Property Matrix
Maintenance Connection
WebRezPro
roomMaster

Request Free Sample Report at https://www.wiseguyreports.com/sample-request/4890273-global-commercial-property-management-software-market-size-status

Market segment by Type, the product can be split into
Cloud Based
Web Base

Market segment by Application, split into
Large Enterprises
SMEs

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Commercial Property Management Software status, future forecast, growth opportunity, key market and key players.
To present the Commercial Property Management Software development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

Table of Content:
1 Report Overview
2 Global Growth Trends
3 Market Share by Key Players
4 Breakdown Data by Type and Application
5 United States
6 Europe
7 China
8 Japan
9 Southeast Asia
10 India
11 Central & South America
12 International Players Profiles
13 Market Forecast 2019-2025
14 Analyst's Viewpoints/Conclusions
15 Appendix

View Detailed Report at https://www.wiseguyreports.com/reports/4890273-global-commercial-property-management-software-market-size-status

About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349
email us here


Source: EIN Presswire

Big Data in Healthcare Market to Witness CAGR of 20% through 2024 | TechSci Research

Big Data in Healthcare Market

Increasing demand for business intelligence to optimize health administration and strategy to drive global big data in healthcare market through 2024

NEW YORK, NEW YORK, UNITED STATES, April 1, 2020 /EINPresswire.com/ — Increasing demand for business intelligence to optimize health administration and strategy to drive global big data in healthcare market through 2024

According to TechSci Research report, “Global Big Data in Healthcare Market By Component, By Deployment, By Analytics Type, By Application, By End User, By Region, Competition, Forecast & Opportunities, 2024”, global big data in healthcare market is expected to grow at a CAGR of 20% during 2019 – 2024, owing to increasing venture capital investments and growing demand for data driven decision making. Increasing adoption of Electronic Health Record, rising healthcare spending and advanced patients’ outcomes are the few factors driving the growth of big data in healthcare market. Moreover, increasing focus on collecting and analyzing data from different platforms to provide better customer experience is promoting the adoption of big data in healthcare sector. Growing adoption of wearable devices and mobile health applications coupled with the need to manage huge amount of critical information is supporting demand for big data in healthcare market. Additionally, growing pressure to improve patient outcomes and curb healthcare spending is anticipated to bolster the growth of the market through 2024.

Browse 19 market data Tables and 132 Figures spread through 150 Pages and an in-depth TOC on "Global Big Data in Healthcare Market"

https://www.techsciresearch.com/report/big-data-in-healthcare-market/4009.html

Global big data in healthcare market can be segmented based on component, software, deployment, analytics type, application, end user and region. Based on deployment, the cloud segment is expected to acquire the dominant share during forecast period as cloud models can be easily customized based on the needs of the customer and its several benefits such as low maintenance and efficient utilization of resources. Moreover, based on the component, the market can be segmented into software and service. Due to increasing demand for analyzing patient records and clinical data, the software segment accounted for the largest share in global big data in healthcare market. Based on Software Type, the Electronic health record software accounted to highest market share of more than 55% in 2018 and is anticipated to grow at the same phase during forecast years. Practice management software of big data in healthcare market accounts for the second largest market share in software type. In terms of analytics type, descriptive analytics type is expected to grow at the highest rate during the next five years as it helps in preventing errors made by doctors and help them reduce risks, improve operations, etc. By application type, financial analytics type accounted for the highest market share in 2018 and is anticipated to dominate the big data in healthcare market during the forecasted years.

Based on end user segment, the finance and insurance agencies are foreseen to attract the highest market share and be the major users of big data in healthcare market owing to the awareness and adoption of health insurance penetration across the globe. Allscripts Healthcare Solutions, Inc., Cerner Corp., Optum, Inc., Premier, Inc., McKesson Corporation, GE Healthcare, Hewlett Packard Enterprise (HPE), International Business Machines Corporation (IBM), Microsoft Corporation, Oracle Corp., etc., are among the leading players operating in global big data in healthcare market. The companies operating in the market are using organic strategies such as product launches, mergers and collaborations to boost their share.

Download Sample Report @ http://www.techsciresearch.com/sample-report.aspx?cid=4009

Customers can also request for 10% free customization on this report.

“North America is at the forefront of global big data in healthcare market and is expected to register significant growth during the forecast period on account of presence of several leading players and initiatives taken by the governments in the region. Moreover, Affordable Care Act (ACA) in the US will promote transparency in healthcare and medical insurance market, which is further anticipated to propel growth of the global big data in healthcare market until 2024.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

“Global Big Data in Healthcare Market By Component, By Software, By Deployment, By Analytics Type, By Application, By End User, By Region, Competition, Forecast & Opportunities, 2024” has evaluated the future growth potential of global big data in healthcare market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in global big data in healthcare market.

About TechSci Research

TechSci Research is a leading global market research firm publishing premium market research reports. Serving 700 global clients with more than 600 premium market research studies, TechSci Research is serving clients across 11 different industrial verticals. TechSci Research specializes in research based consulting assignments in high growth and emerging markets, leading technologies and niche applications. Our workforce of more than 100 fulltime Analysts and Consultants employing innovative research solutions and tracking global and country specific high growth markets helps TechSci clients to lead rather than follow market trends.

Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017

Tel: +1-646-360-1656

Email: sales@techsciresearch.com

New Age TechSci
New Age TechSci Research Pvt Ltd
+ +1 646 360 1656
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Data Center Life Cycle Services 2020 Global Market – Opportunities, Challenges, Strategies & Forecasts 2023

PUNE, MAHARASTRA, INDIA, April 1, 2020 /EINPresswire.com/ —

WiseGuyReports.Com Publish a New Market Research Report On –“ Data Center Life Cycle Services 2020 Global Market – Opportunities, Challenges, Strategies & Forecasts 2023”.

Data Center Life Cycle Services Market 2020

Description: –

This report analyzes the data center life cycle services market by component (hardware, software), by deployment, by data center type (mid-size data center, enterprise data center, large data center), by service and by vertical; it also studies the top manufacturers in the market.
The global data center life cycle services market is expected to reach USD 7 billion by 2023, at a CAGR of 15% during the forecast period 2017 – 2023.

Get a Sample Report @ https://www.wiseguyreports.com/sample-request/3638149-data-center-life-cycle-services-market-research-report-forecast-2023

For more information or any query mail at sales@wiseguyreports.com

Major Key Players Listed Are:

• Schneider Electric (France)
• HP (U.S.)
• IBM Corporation (U.S.)
• Vertiv (U.S.)
• Nlyte Software (U.S.)
• Optimum Path, Inc. (U.S.)
• Raritan (U.S.)
• CA Technologies (U.S.)
• FieldView Solutions, Inc. (U.S.)
• Huawei Technologies Co. Ltd. (China)

Market dynamics

This report has offered the readers with the fast-paced expansions in the Data Center Life Cycle Services market. It includes a detailed study of the basic dynamics structure of the global market such as the impacting factors and the growing focus on the usage of the product/service by the customers. The increase in population and the numerous technological innovations have led to the growth of the market besides the restraints are affecting the growth of the industry such as unfavorable scenarios and the lack of skilled labour, etc.

Segmental analysis

The report hands out the segmental description of the Data Center Life Cycle Services market on the basis of various aspects along with the regional segmentation. This segmentation has been carried out to attain an overall detailed perspective in the Data Center Life Cycle Services market with the market size analysis and the growth analysis by region. The market attractiveness index is also provided in the global report. These factors have affected the regions of North America, Europe, Asia Pacific, Latin America, South and Central America, Africa, and the Middle East.

Method of research

The global Data Center Life Cycle Services market shows the industry analysis and research that helps to get a clearer picture of the latest trending practices and numerous analyses in the global market. Porter’s Five Forces Analysis has been adopted to gauge various parameters as well as the regulatory analysis for the research purposes. The methods of research also include the supervision and investigation of key companies. Along with this, the SWOT analysis has also been conducted for enabling faster decision making of the reader about the Data Center Life Cycle Services market report.

Key Players

The competitive landscape among the key players points towards the participation and involvement of these players in the global Data Center Life Cycle Services market. This analysis has been carried out for understanding the strategy analysis of the product/service. Various mergers, agreements and acquisitions analysis has also been done by the market report.

Enquiry About Report @ https://www.wiseguyreports.com/enquiry/3638149-data-center-life-cycle-services-market-research-report-forecast-2023

Table of Contents – Major Key Points

1 Market Introduction

2 Research Methodology

3 Market Dynamics

4 Executive Summary

5. Market Factor Analysis

6 Data Center Life Cycle Services Market, By Segments

7 Competitive Analysis

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349
email us here


Source: EIN Presswire

Alkyd Resin Industry Global Production Analysis, Demand By Regions, Segments And Applications 2020-2023

PUNE, MAHARASTRA, INDIA, April 1, 2020 /EINPresswire.com/ —

WiseGuyReports.Com Publish a New Market Research Report On –“ Alkyd Resin Industry Global Production Analysis, Demand By Regions, Segments And Applications 2020-2023”.

Alkyd Resin Market 2020

Description: –

The global alkyd resin market is estimated to value at USD 2,610 million in 2016 and is projected to reach USD 3,257.7 million by 2023. Growing demand for alkyd resins in architectural coating along with wood furnishing is expected to drive the market growth. Moreover, increasing demand for automotive refinishes are likely to augment the market growth owing to high insurance cost, replacement demand from household swapping their old vehicles, and rising expenditure in vehicle refinish.

The report offers segmentation analysis based on type such as oil-based, modified, water reducible, and others. Furthermore, the oil-based alkyd resin is sub-segmented into short oil, medium oil, and long oil. Among all the alkyd resins types, oil-based dominated the global market in 2016 with a significant market shares of 41.8% at highest CAGR of 3.07%. The long oil is leading the alkyd resin sub-segment owing to high durability, gloss retention, and flexibility. With superior performance of alkyd resins, they are used in numerous application such as building & construction, automotive, industrial, furniture, and others. Building & construction is a fastest growing segment and accounts for a market share of 36.0% by the end of 2016. Increasing expenditure on residential as well as non-residential activities across the globe is slated to drive the market growth. Nevertheless, shifting preference towards water-borne resin technology due to less VOC content are likely to provide a lucrative opportunity to market players.

Get a Sample Report @ https://www.wiseguyreports.com/sample-request/3517561-global-alkyd-resin-market-research-report-forecast-to-2023

For more information or any query mail at sales@wiseguyreports.com

Major Key Players Listed Are:

Some of the major players operating in the global alkyd resin market are Polynt SpA, Nord Composites, Mancuso Chemicals Limited, D.S.V Chemicals Pvt Ltd., Macro Polymers, BASF SE, Spolchemie, DowDuPont Inc., DSM, Arkema SA, and Cytech Solvay Group.

Market dynamics

This report has offered the readers with the fast-paced expansions in the Alkyd Resin market. It includes a detailed study of the basic dynamics structure of the global market such as the impacting factors and the growing focus on the usage of the product/service by the customers. The increase in population and the numerous technological innovations have led to the growth of the market besides the restraints are affecting the growth of the industry such as unfavorable scenarios and the lack of skilled labour, etc.

Segmental analysis

The report hands out the segmental description of the Alkyd Resin market on the basis of various aspects along with the regional segmentation. This segmentation has been carried out to attain an overall detailed perspective in the Alkyd Resin market with the market size analysis and the growth analysis by region. The market attractiveness index is also provided in the global report. These factors have affected the regions of North America, Europe, Asia Pacific, Latin America, South and Central America, Africa, and the Middle East.

Method of research

The global Alkyd Resin market shows the industry analysis and research that helps to get a clearer picture of the latest trending practices and numerous analyses in the global market. Porter’s Five Forces Analysis has been adopted to gauge various parameters as well as the regulatory analysis for the research purposes. The methods of research also include the supervision and investigation of key companies. Along with this, the SWOT analysis has also been conducted for enabling faster decision making of the reader about the Alkyd Resin market report.

Key Players

The competitive landscape among the key players points towards the participation and involvement of these players in the global Alkyd Resin market. This analysis has been carried out for understanding the strategy analysis of the product/service. Various mergers, agreements and acquisitions analysis has also been done by the market report.

Enquiry About Report @ https://www.wiseguyreports.com/enquiry/3517561-global-alkyd-resin-market-research-report-forecast-to-2023

Table of Contents – Major Key Points

1 Introduction

2 Research Methodology

3 Market Dynamics

4 Market Factor Analysis

5 Global Alkyd Resin Market, by Component

6 Global Alkyd Resin Market, by Delivery Mode

7 Global Alkyd Resin Market, by Application

8 Global Alkyd Resin Market, by End-User

9 Global Alkyd Resin By Region

10 Company Landscape

Continued…

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349
email us here


Source: EIN Presswire

Emergency Department Information System Market Segmentation, Application, Trends, Opportunity & Forecast 2020 To 2023

PUNE, MAHARASTRA, INDIA, April 1, 2020 /EINPresswire.com/ —

WiseGuyReports.Com Publish a New Market Research Report On –“ Emergency Department Information System Market Segmentation, Application, Trends, Opportunity & Forecast 2020 To 2023”.

Emergency Department Information System Market 2020

Description: –

For the management of data and the workflow and also for supporting the emergency division of the patient care and other operations, the emergency department information systems are used. This is one of the electronic health record systems whose main function is to support the medical care in emergency situations like clinical documentation, triage, patient entry, resource, and patient tracking, and others. Global Emergency Department Information System market is anticipated to grow at a CAGR of 15.10% during the prediction period 2017-2023.

With better technological healthcare, hospitals are also getting advanced. The healthcare centers are now providing their patients with specialized medical treatment along with better nursing facilities. Also, the growing number of hospitals in the developing and the developed economies are augmenting the growth of the global Emergency department information systems market. The emergency department information systems market is driven by the increasing demand for the various data-driven technologies, mounting emergency departmental visits, growing the older population, and the swelling number of hospitals along with the growing number of people adopting the insurance coverage.

Get a Sample Report @ https://www.wiseguyreports.com/sample-request/3633003-emergency-department-information-system-market-information-component-software

For more information or any query mail at sales@wiseguyreports.com

Major Key Players Listed Are:

Some of the key players in the global emergency department information system market are Cerner Corporation, Allscripts, Epic Systems, Healthland, Inc, Mckesson Corporation, Evident, Logibec Canada, EPOWERdoc, Inc, T-System Inc, Medical Information Technology, Inc, Siemens Healthcare, Medhost Inc, veEDIS Clinical Systems LLC, Unitedhealth Group, Inc, Wellsoft and others.

Market dynamics

This report has offered the readers with the fast-paced expansions in the Emergency Department Information System market. It includes a detailed study of the basic dynamics structure of the global market such as the impacting factors and the growing focus on the usage of the product/service by the customers. The increase in population and the numerous technological innovations have led to the growth of the market besides the restraints are affecting the growth of the industry such as unfavorable scenarios and the lack of skilled labour, etc.

Segmental analysis

The report hands out the segmental description of the Emergency Department Information System market on the basis of various aspects along with the regional segmentation. This segmentation has been carried out to attain an overall detailed perspective in the Emergency Department Information System market with the market size analysis and the growth analysis by region. The market attractiveness index is also provided in the global report. These factors have affected the regions of North America, Europe, Asia Pacific, Latin America, South and Central America, Africa, and the Middle East.

Method of research

The global Emergency Department Information System market shows the industry analysis and research that helps to get a clearer picture of the latest trending practices and numerous analyses in the global market. Porter’s Five Forces Analysis has been adopted to gauge various parameters as well as the regulatory analysis for the research purposes. The methods of research also include the supervision and investigation of key companies. Along with this, the SWOT analysis has also been conducted for enabling faster decision making of the reader about the Emergency Department Information System market report.

Key Players

The competitive landscape among the key players points towards the participation and involvement of these players in the global Emergency Department Information System market. This analysis has been carried out for understanding the strategy analysis of the product/service. Various mergers, agreements and acquisitions analysis has also been done by the market report.

Enquiry About Report @ https://www.wiseguyreports.com/enquiry/3633003-emergency-department-information-system-market-information-component-software

Table of Contents – Major Key Points

1 Introduction

2 Research Methodology

3 Market Dynamics

4 Market Factor Analysis

5 Global Emergency Department Information System Market, by Component

6 Global Emergency Department Information System Market, by Delivery Mode

7 Global Emergency Department Information System Market, by Application

8 Global Emergency Department Information System Market, by End-User

9 Global Emergency Department Information System By Region

10 Company Landscape

Continued…

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349
email us here


Source: EIN Presswire

Only Wide-Scale Use of a Fully At-Home Test Will Make a Dent in COVID-19

An at-home blood test that uses a finger prick to sample blood.

We already have a great prototype for an at-home blood test, and millions of Americans already use it every day.

To win this war and save American lives, we need an at-home sampling and processing blood test, and we need it soon.

BOSTON, MASSACHUSETTS, UNITED STATES, March 31, 2020 /EINPresswire.com/ — There was justifiable excitement when Abbott announced a new 5-minute test for COVID-19, the disease caused by the novel coronavirus. More rapid and widespread testing at point-of-care will do much to help us win this war.

Ultimately, though, hospital-based or office-based testing devices, like Abbotts, aren’t going to make a big-enough dent in this battle. Only at-home sample collecting and processing will truly help us get our arms around this enormously difficult to defeat new enemy and defeat it.

In my earlier article, I outlined a 3-step plan to save lives. The third, and arguably most important, step of that plan is the rapid wide-scale deployment of a fully at-home blood test for COVID-19. In this article, I will more fully explain why this is so critical, and so doable, financially, technologically and psychologically.

WE ALREADY HAVE A PROTOTYPE UNDER WIDESPREAD USE

Can you imagine a diabetic going to the hospital four times a day, 365 days a year, to get his or her blood-sugar level tested? Because diabetics need frequent, easy-to-use blood tests, the market responded with an at-home sampling AND processing kit that helps millions of American diabetics manage their condition fully at-home.

Without this tool, it is safe to assume that many diabetics would be flying blind, living their lives at the whims of an invisible killer – much as we are today with the coronavirus.

The 5-minute Abbott test is a game-changer, to be sure. The President, the FDA, and private business should be applauded for expediting its development and approval.

But touting it as a patient/consumer-centered test is misleading. It’s only a “5-minute test” if you live at a hospital or doctor’s office. For many Americans, particularly those who rely on public transportation, the start-to-finish testing process could actually consume at least four-and-a-half hours.

This, obviously, is an impractical and psychologically intolerable amount of time for most Americans, if you want them to test themselves (and others) every time they seek entry back into their “virus-free” homes. Yet, this would be the price they would have to pay, daily, if they went back to work at their plant or office.

If you were a soldier in a foxhole, would it be reasonable to expect you to spend four hours every time you need to get a bullet to fire your next round?

HERE'S EXACTLY WHAT WE NEED

What we need to win the war as soon as possible is a test kit having ALL of the following features:

1. Very fast results: If we plan to keep our homes a virus-free safe haven, we need to be able to quickly test anyone who seeks entry into it. This means we need super-fast (no longer than 15-minutes, and preferably 5-minutes) sampling and processing, combined, i.e. as fast as the current finger-prick blood sugar testing.
2. Mobile: So we can use it at home or on the road.
3. Convenient: Easy-to-carry and low-profile, so that it can be kept in the average entry way.
4. Ease-of-use: A simple finger prick should do it. The current nasal- and throat-swabs are difficult to do correctly (meaning a high, very dangerous, false-negative rate) and painful for the patient.
5. No time, energy, or transportation costs: Quick, easy, and at-home.
6. Low-aggregate costs: No personnel or labs needed to sample or interpret results.
7. No prior-authorization needed: Nobody should need an order from their doctor to quickly learn if they have COVID-19. Test can be done any time, day or night.
8. High-quality and “idiot-proof”: No medical – or even high school – degree needed.
9. Safe and effective: Proven repeatedly over many years of use.
10. Highly accurate: Very low error rate, especially dangerous false-negative rate

THREE COMPANIES READY TO ROLL

I personally know of three companies that, if soon they receive adequate funding for further development, manufacturing, and distribution, and robust regulatory support, can very quickly help us accomplish the goal of having a large-scale at-home-test program that could meet these requirements, nationwide.

Why are all of those features of great importance? Because, if the tests aren’t widely and aggressively used, we won’t come close to being able to save, by my count, 50,000 American lives. It would be like performing D-Day with only 1,000 soldiers, instead of 156,000.

Gen. Eisenhower didn’t do it, and I don’t believe President Trump will either. He is looking for “The One Big Thing,” a knock-out punch.

Based on my decades of experience in the health sciences, including previously serving as the Principal Deputy Commissioner of the U.S. Food and Drug Administration, I know that at-home-sample-collection and processing, which will help us accomplish aggressive testing in enormous numbers, is the only way we are going to win this war.

This is doable. We just need our leaders to make this Phase I of my plan happen, very, very soon.

The Hon. John Norris is an FDA Former Principal Deputy Commissioner, a Harvard Former Health Policy and Management Faculty Member, a Massachusetts Former Chairman of the Clinical Laboratory Regulation Reform Commission, and Chairman of FDTH Regulatory Affairs Strategies, as well as an inventor-entrepreneur and frequent drug, device, Healthcare-IT, clinical lab, and hospital-system visionary, innovator, advisor, and board member. He can be reached at john.norris.jd.mba@fdthregulatoryaffairsstrategies.com.

John Norris
FDTH Regulatory Affairs Strategies
+1 617-680-3127
email us here


Source: EIN Presswire

Company That just Released World’s First Saliva Test for Autism Opens Up Investment Opportunity to the Public

Quadrant Biosciences logo, invest, epigenetics, autism

Quadrant Biosciences

Quadrant Biosciences offers common shares through equity crowdfunding platform

SYRACUSE, NEW YORK, UNITED STATES, March 31, 2020 /EINPresswire.com/ — Company That just Released World’s First Saliva Test for Autism Opens Up Investment Opportunity to the Public

Quadrant Biosciences offers common shares through equity crowdfunding platform

Quadrant Biosciences Inc (“Quadrant Biosciences”), a leading developer of epigenetic diagnostic solutions, including the world's first saliva test for autism, announced that it is now offering common shares of the company (at a price of $3/share, with a minimum investment of $300) through equity crowdfunding platform Wefunder. The Reg A plus campaign is Quadrant’s first offering of common shares to the public — the company has previously raised over $32 million through private sales of its common shares to accredited investors only.

Quadrant Biosciences is a life science company that leverages new discoveries in the field of epigenetics and microbiome research to develop novel diagnostic solutions to many of today's critical health care challenges. In December, the company commercially released Clarifi ASD™, the first of its kind epigenetic saliva test to aid the diagnosis of autism in children 18 months through six years of age. Quadrant Biosciences collaborated with researchers from SUNY Upstate Medical University and Penn State College of Medicine to create this novel biological test that is based on the genetic sequencing and molecular analysis of regulatory RNAs and microbes in the saliva.

Clarifi ASD™is the first product to be launched from the company's Clarifi™ Epigenetic Diagnostic Platform. According to Quadrant CEO and Founder Richard Uhlig, several other tests using the same epigenetic research and next-generation sequencing technology are currently under research and development. “Our collaborative research with SUNY Upstate Medical and Penn State College of Medicine has shown that the same approach we used for developing the Clarifi autism saliva test – evaluating epigenetic molecules found in the saliva – is demonstrating similar diagnostic utility for other neurological diseases such as Parkinson's Disease and Concussion Injuries. It is exciting and extremely gratifying to be on the forefront of these life-changing discoveries.”

Prospective investors interested in learning more about Quadrant Biosciences and the investment opportunity can review offering documents and other information about the company at https://www.quadrantbiosciences.com/investor-relations/

AN OFFERING STATEMENT REGARDING THIS OFFERING HAS BEEN FILED WITH THE SEC. THE SEC HAS QUALIFIED THAT OFFERING STATEMENT, WHICH ONLY MEANS THAT THE COMPANY MAY MAKE SALES OF THE SECURITIES DESCRIBED BY THE OFFERING STATEMENT. IT DOES NOT MEAN THAT THE SEC HAS APPROVED, PASSED UPON THE MERITS OR PASSED UPON THE ACCURACY OR COMPLETENESS OF THE INFORMATION IN THE OFFERING STATEMENT. YOU MAY OBTAIN A COPY OF THE OFFERING CIRCULAR THAT IS PART OF THAT OFFERING STATEMENT FROM HERE. YOU SHOULD READ THE OFFERING CIRCULAR BEFORE MAKING ANY INVESTMENT.
See the NCPS Offerings Disclosure here.
Securities offered through North Capital Private Securities, member FINRA/SIPC.

Investment risk – liquidity, risk of loss; Not tax, investment, accounting advice; past performance not indicative of future results; consult with a professional (attorney, advisor, accountant); conduct your own research and due diligence; forward looking statements; information believed to be correct but don't rely upon it / no warranty; not an offer to sell securities; information may not be complete; investments not suitable for all investors; not a recommendation; platforms are not brokers; member FINRA and SIPC

THE OFFERING MATERIALS MAY CONTAIN FORWARD-LOOKING STATEMENTS AND INFORMATION RELATING TO, AMONG OTHER THINGS, THE COMPANY, ITS BUSINESS PLAN AND STRATEGY, AND ITS INDUSTRY. THESE FORWARD-LOOKING STATEMENTS ARE BASED ON THE BELIEFS OF, ASSUMPTIONS MADE BY, AND INFORMATION CURRENTLY AVAILABLE TO THE COMPANY’S MANAGEMENT. WHEN USED IN THE OFFERING MATERIALS, THE WORDS “ESTIMATE,” “PROJECT,” “BELIEVE,” “ANTICIPATE,” “INTEND,” “EXPECT” AND SIMILAR EXPRESSIONS ARE INTENDED TO IDENTIFY FORWARD-LOOKING STATEMENTS, WHICH CONSTITUTE FORWARD LOOKING STATEMENTS. THESE STATEMENTS REFLECT MANAGEMENT’S CURRENT VIEWS WITH RESPECT TO FUTURE EVENTS AND ARE SUBJECT TO RISKS AND UNCERTAINTIES THAT COULD CAUSE THE COMPANY’S ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE CONTAINED IN THE FORWARD-LOOKING STATEMENTS. INVESTORS ARE CAUTIONED NOT TO PLACE UNDUE RELIANCE ON THESE FORWARD-LOOKING STATEMENTS, WHICH SPEAK ONLY AS OF THE DATE ON WHICH THEY ARE MADE. THE COMPANY DOES NOT UNDERTAKE ANY OBLIGATION TO REVISE OR UPDATE THESE FORWARD-LOOKING STATEMENTS TO REFLECT EVENTS OR CIRCUMSTANCES AFTER SUCH DATE OR TO REFLECT THE OCCURRENCE OF UNANTICIPATED EVENTS.
.
About Quadrant Biosciences
Quadrant Biosciences is a life science company involved in the development of functional assessments and epigenetic diagnostic solutions for large-scale health issues. The company has entered into collaborative research relationships with a number of institutions including SUNY Upstate Medical University and Penn State University to explore and develop novel biomarker technologies with a focus on Autism Spectrum Disorder, concussion, and Parkinson's Disease. Quadrant Biosciences also participates in the Start-up NY program, a New York State economic development program. For more information, please visit www.quadrantbiosciences.com.

David MacLean
Quadrant Biosciences
+1 315-614-2325
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Singapore Pharmaceutical Market Outlook 2017-2030 – by Goldstein Market Intelligence

, In 2016, Singapore government invested around USD 13 billion in the development of healthcare facilities in the region.

NEW YORK, NY, UNITED STATES OF AMERICA, March 31, 2020 /EINPresswire.com/ — Singapore Pharmaceutical Market Outlook 2017-2030 – by Goldstein Market Intelligence

According to the Goldstein Market Intelligence forecast, In 2016, Singapore government invested around USD 13 billion in the development of healthcare facilities in the region. As per Ministry of Singapore Health, there were 12,000 hospital beds in 25 hospitals and specialty centers in Singapore.
A more recent investment of $1 billion to develop several research institutes and the Biopolis R&D complex. Together, the investments have attracted more than 30 major global life-sciences companies and created an effective ecosystem that harnesses the benefits of economies of scale and knowledge transfer. The first tier of protection comprises government subsidies of up to 80 percent of the total cost of care provided in public hospitals and primary care polyclinics. This is supported by a group of savings and insurance programs known as the “3Ms” system—for Medisave, MediShield, and Medifund—which plays a critical role in maintaining the public’s health and welfare.

Report is available at :- https://bit.ly/2Uv4YIp
Market dynamic / Drivers & Restraints to Market Growth
Increase in aging population and focusing on fitness & healthy lifestyle is predicted to rise the Singapore pharmaceuticals market. Rise in aging population in many nations across the globe is a major a growth driver for the pharmaceutical industry. Occupational stress across diverse work settings including job insecurity, work hours, job quality (job strain, job control) and wages.
Meanwhile, the innovative pharmaceutical industry is currently facing unprecedented challenges caused by slower sales growth, expiring patents, increasing competition from generics, shorter product life cycles, tighter regulations, adverse media coverage and reputational damage, and a decline in the number of new innovative drugs under development.

Request for Sample Report at :- https://bit.ly/2WSoHDI

Covered in this Singapore Pharmaceutical Market Outlook 2030 Report are
“Singapore Pharmaceutical Market Outlook 2030” by Goldstein Research contains detailed overview of Singapore Pharmaceutical Market in terms of market segmentation by analysis basis, therapy type and geography. The Report highlights the competitive outlook of major global players that includes the business strategies, product portfolio, revenue distribution, financial analysis, R&D activities, and investments. The in-depth analysis of POS Terminal Market report will help the clients to assess their business strategies as per the competitive environment in the market space.

Major players covered in this POS Terminal Market report are:
• GlaxoSmithKline (GSK)
• Abbot Laboratories
• Lonza
• Merck Sharp & Dohme
• Takeda
• Roche Holding AG
• Pfizer Inc.
• Raffles Medical Group Ltd.
• Wave Life Sciences
• Sphaera Pharma
• Special Access Pharma
• Pharmaskin
• NCI Health
• Melbourne Drugs

Further, Singapore Pharmaceutical Market Report encompasses the major trends & opportunities, market dynamics and other growth factors of the market Singapore Pharmaceutical Market outlook also comprises of key challenges, risk analysis, BPS analysis, SWOT Analysis and Market Attractiveness. The report also highlights the expert analysis to provide a complete overview of the market including the PESTLE analysis of each region and country.
About Goldstein Research
Based in the US, Goldstein Research currently has a strong presence in the American and Asian countries. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions.
Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear-cut forecasts. Our market research reports provide in-depth analysis of global and regional variations along with competitors’ overview.
Our analysts working on chemicals construction to help various tech-giants, tech start-ups and entry players to assess the current and upcoming business scenario. We believe in the vigorous examination of the current market scenario and build around creative ideas and approaches that are most suitable to our clients’ needs and business agenda.

Contact for more Info:

Dennis Abraham
(Global Sales Head)

UK:
+44 7520 644482
dennis.abraham@goldsteinresearch.com
www.goldsteinresearch.com

Steve Blades
Goldstein Research
+1 646-568-7747
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Silica Aerogel Exports From China 2017-2030 Outlook – By Goldstein Market Intelligence

Changzhou National Hi-Tech District consented to an arrangement,underneath which China greatest aerogel materials fabricating base will be built up in locale.

NEW YORK, NY, UNITED STATES OF AMERICA, March 31, 2020 /EINPresswire.com/ — Silica Aerogel Exports From China 2017-2030 Outlook – By Goldstein Market Intelligence
According to the Goldstein Market Intelligence report , Changzhou National Hi-Tech District consented to an arrangement, underneath which China's greatest aerogel materials fabricating base will be built up in the locale. Changzhou National Hi-Tech District intends to place in an excited assurance to acquire more than 10 aerogel creation offices inside five years, with the conviction of delivering a yield esteem anticipated at 10 billion yuan (approx. USD 1.5 billion).
Silica aerogel warm protection in current structures has become a basic method to meet the troubles of upgraded vitality productivity, by which the conduction of warmth through dividers, roofs, windows rooftops and floors can be impeded effectively. In addition, rising interest from North America and European markets will give the significant lift to the Chinese aerogels fabricating industry.

Report is available at:- https://bit.ly/2UOiOEN
Covered in this China Silica Aerogel Exports Market Report are
“China Silica Aerogel Exports Market Outlook 2030” by Goldstein Research contains detailed overview of China Silica Aerogel Exports Market in terms of market segmentation by analysis basis, therapy type and geography. The Report highlights the competitive outlook of major global players that includes the business strategies, product portfolio, revenue distribution, financial analysis, R&D activities, and investments. The in-depth analysis of China Silica Aerogel Exports Market report will help the clients to assess their business strategies as per the competitive environment in the market space.
Major players covered in this China Silica Aerogel Exports Market report are:
Aspen Aerogels
Cabot Corporation
Aerogel Technologies
Nano High-Tech
Guangdong Alison Hi-Tech
Active Aerogels
Enersens
Jios Aerogel Corporation
Insulgel High-Tech
Protective Polymers
BASF
Guizhou Aerospace
Green Earth
Aerogel Technologies (GEAT).

Request for Sample Report at:- https://bit.ly/3bGfouQ
Further, China Silica Aerogel Exports Market Report encompasses the major trends & opportunities, market dynamics and other growth factors of the market. China Silica Aerogel Exports Market outlook also comprises of key challenges, risk analysis, BPS analysis, SWOT Analysis and Market Attractiveness. The report also highlights the expert analysis to provide a complete overview of the market including the PESTLE analysis of each region and country.
About Goldstein Research
Based in the US, Goldstein Research currently has a strong presence in the American and Asian countries. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions.
Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear-cut forecasts. Our market research reports provide in-depth analysis of global and regional variations along with competitors’ overview.
Our analysts working on chemicals construction to help various tech-giants, tech start-ups and entry players to assess the current and upcoming business scenario. We believe in the vigorous examination of the current market scenario and build around creative ideas and approaches that are most suitable to our clients’ needs and business agenda.

Contact for more Info:

Dennis Abraham
(Global Sales Head)

UK:
+44 7520 644482
dennis.abraham@goldsteinresearch.com
www.goldsteinresearch.com

Steve Blades
Goldstein Research
+1 646-568-7747
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

ExAM4Inspections providing standardized Infectious Disease Control software to hospitals

ExAM4Inspections.com Logo

ExAM4Inspections.com

MBA Logo

MBA Logo

MB&A providing its ExAM4Inspections.com solution supporting infectious disease control and healthcare associated infection solutions to the healthcare market.

Our IDC and HAI accelerators will enable our customers to get programs started faster than ever before which is especially important right now as we work to stop the spread of COVID-19.”

— Bradley Hilker, Strategic Account Executive

ARLINGTON, VIRGINIA, UNITED STATES, March 31, 2020 /EINPresswire.com/ — Millsapps, Ballinger & Associates, LLC (MB&A) announced that they are delivering standardized rollout and delivery of the companies ExAM4Inspections.com Salesforce AppExchange product (ExAM) in support of Infectious Disease Control (IDC) and Healthcare Associated Infections (HAI). The approach has been used at more than a dozen hospitals to date and promises a standardized and rapid on boarding that helps hospitals respond to the need to control infectious diseases.

The standardization of key programs ExAM supports such as Hand Hygiene (HH), Sterile Processing, Operating Room Inspections and Patient Care Area Quality Assurance Inspections form a critical component of a hospital’s front line in the fight against infection. With the rise of COVID-19 (Coronavirus), programs like these help hospitals understand and employ best practices with regard to ensuring basic patient and caregiver safety.

Even before the onset of COVID-19, healthcare leadership has been pushing tirelessly for funding to support Infection Prevention and Control (IPC) programs to assure their facilities are taking the necessary steps to combat the spread of viruses and other infectious diseases. As an example one of our customers at Martinsburg VA Medical Center estimates in an internal cost benefit analysis the implementation of ExAM4Inspections would enable them to “reallocate 536 hours of IPC time currently spent performing administrative tasks to more specialized Infection Prevention and Control duties. Although the value of IPC time can be challenging to precisely quantify, reallocation towards additional prevention, training and education is worthwhile considering a single S. aureus bloodstream infection recently cost facilities more than $100,000.” This was of course written prior to the COVID-19 pandemic, but it hints at the scale of the cost reduction in human lives and dollars that could be achieved by leveraging the Salesforce AppExchange product ‘ExAM4Inspections’ to confirm proper standards are met, and to enable leadership to make necessary decisions and adjustments in real time.

MB&A has been awarded the CIO Applications Top 25 Salesforce Solution Providers of 2019. MB&A was recognized for their groundbreaking Salesforce AppExchange product ExAM (ExAM4Inspections.com) which is currently being used to enable adherence to standards at hospitals nationwide.

Learn More at ExAM4Inspections.com

Bradley Hilker
MB&A
+1 703-973-5404
email us here


Source: EIN Presswire